Renovaro Inc. (RENB)
NASDAQ: RENB · Real-Time Price · USD
0.3352
+0.0120 (3.71%)
At close: May 13, 2025, 4:00 PM
0.3231
-0.0121 (-3.61%)
Pre-market: May 14, 2025, 8:30 AM EDT
Renovaro Employees
Renovaro had 25 employees as of June 30, 2024. The number of employees increased by 13 or 108.33% compared to the previous year.
Employees
25
Change (1Y)
13
Growth (1Y)
108.33%
Revenue / Employee
n/a
Profits / Employee
-$4,736,418
Market Cap
58.23M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
RENB News
- 23 hours ago - Renovaro and Amsterdam University Medical Center Announce Exclusive Collaboration to Advance Blood Platelet RNA Diagnostics - GlobeNewsWire
- 21 days ago - Renovaro Secures High-Powered Computing from Nebul Through a Partnership to Accelerate Next-Generation Biomarker Discovery and Diagnostic Programs - GlobeNewsWire
- 4 weeks ago - Renovaro and BioSymetrics Close Merger to Accelerate AI-Driven Biomarker Discovery and Precision Medicine - GlobeNewsWire
- 5 weeks ago - Renovaro Provides Update to Definitive Agreement with Predictive Oncology - GlobeNewsWire
- 2 months ago - Renovaro Completes First Milestone Payment to Finalize Definitive Agreement with Predictive Oncology - GlobeNewsWire
- 2 months ago - Renovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision Medicine - GlobeNewsWire
- 2 months ago - Renovaro Announces $15 million in Equity Committed - GlobeNewsWire
- 4 months ago - PREDICTIVE ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Predictive Oncology Inc. - POAI - Business Wire